Efficient shRNA delivery into B and T lymphoma cells using lentiviral vector-mediated transfer
Open Access
- 19 November 2008
- journal article
- research article
- Published by Springer Nature in Journal of Hematopathology
- Vol. 2 (1) , 9-19
Abstract
RNA interference is a powerful tool for the functional analysis of proteins by specific gene knockdown. In this study, we devised a rapid and efficient way to screen suitable siRNA sequences and subsequently employ them for specific gene knockdown in usually hard-to-transfect lymphoid cell lines, using a self-inactivating lentiviral vector. Two proteins with different half-lives were chosen, cyclin D1 and STAT3. A specific lacZ reporter fusion assay was used to identify highly effective siRNA sequences. Only siRNA molecules with more than 85% of knockdown efficiency were selected for the generation of lentiviral transfer vectors. Transduction rates of 75–99% were achieved in the lymphoma cell lines Granta 519 (mantle cell lymphoma), Karpas 299, and SUDHL-1 (anaplastic large T cell lymphoma), as demonstrated by green fluorescent protein expression in fluorescence-activated cell sorting analysis. The high level of transduction efficiency allows RNA interference studies to be performed on transduced cells without further manipulation, such as cell sorting or cloning. The LacZ reporter system together with the lentivirus technology is a very important tool in the hematology field, which enables experiments in lymphoid cells that were not possible before.Keywords
This publication has 25 references indexed in Scilit:
- Effect of target secondary structure on RNAi efficiencyRNA, 2007
- NPM-ALK–dependent expression of the transcription factor CCAAT/enhancer binding protein β in ALK-positive anaplastic large cell lymphomaBlood, 2006
- Efficient gene transfer into primary human natural killer cells by retroviral transductionExperimental Hematology, 2005
- RNA interference in biology and diseaseBlood, 2005
- Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic targetNature Medicine, 2005
- Local RNA Target Structure Influences siRNA Efficacy: Systematic Analysis of Intentionally Designed Binding RegionsJournal of Molecular Biology, 2005
- Inhibition of STAT3 expression by siRNA suppresses growth and induces apoptosis in laryngeal cancer cellsActa Pharmacologica Sinica, 2005
- Factors Influencing the Titer and Infectivity of Lentiviral VectorsHuman Gene Therapy, 2004
- Transient transfection of primary T helper cells by particle-mediated gene transferJournal of Immunological Methods, 1998
- Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway.Genes & Development, 1997